Literature DB >> 12553669

Vimentin intermediate filament reorganization by Cdc42: involvement of PAK and p70 S6 kinase.

Wing Chan1, Robert Kozma, Yoshihiro Yasui, Masaki Inagaki, Thomas Leung, Ed Manser, Louis Lim.   

Abstract

Rho family GTPases play a major role in actin cytoskeleton reorganization. Recent studies have shown that the activation of Rho family GTPases also induces collapse of the vimentin intermediate filament (IF) network in fibroblasts. Here, we report that Cdc42V12 induces the reorganization of vimentin IFs in Hela cells, and such reorganization is independent of actin and microtubule status. We analyzed the involvement of three serine/threonine kinase effectors, MRCK, PAK and p70 S6K in the Cdc42-induced vimentin reorganization. Surprisingly, the ROK-related MRCK is not involved in this IF reorganization. We detected phosphorylation of vimentin Ser72, a site phosphorylated by PAK, after Cdc42 activation. PAK inhibition partially blocked Cdc42-induced vimentin IF collapse suggesting the involvement of other effectors. We report that p70 S6 kinase (S6K)1 participates in this IF rearrangement since the inhibitor rapamycin or a dominant inhibitory S6K could reduce the Cdc42V12 or bradykinin-induced vimentin collapse. Further, inhibition of PAK and S6K in combination very effectively prevents Cdc42-induced vimentin IF collapse. Conversely, only in combination active PAK and S6K could induce a vimentin IF rearrangement that mimics the Cdc42 effect. Thus, Cdc42-induced vimentin reorganization involves PAK and, in a novel cytoskeletal role, p70 S6K.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12553669     DOI: 10.1078/0171-9335-00281

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  15 in total

1.  Microtubule-dependent transport of vimentin filament precursors is regulated by actin and by the concerted action of Rho- and p21-activated kinases.

Authors:  Amélie Robert; Harald Herrmann; Michael W Davidson; Vladimir I Gelfand
Journal:  FASEB J       Date:  2014-03-20       Impact factor: 5.191

Review 2.  Intermediate filaments in smooth muscle.

Authors:  Dale D Tang
Journal:  Am J Physiol Cell Physiol       Date:  2008-02-06       Impact factor: 4.249

3.  Critical role of vimentin phosphorylation at Ser-56 by p21-activated kinase in vimentin cytoskeleton signaling.

Authors:  Qing-Fen Li; Amy M Spinelli; Ruping Wang; Yana Anfinogenova; Harold A Singer; Dale D Tang
Journal:  J Biol Chem       Date:  2006-09-20       Impact factor: 5.157

4.  Silencing of p21-activated kinase attenuates vimentin phosphorylation on Ser-56 and reorientation of the vimentin network during stimulation of smooth muscle cells by 5-hydroxytryptamine.

Authors:  Dale D Tang; Ying Bai; Susan J Gunst
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

5.  Role of vimentin in smooth muscle force development.

Authors:  Ruping Wang; Qingfen Li; Dale D Tang
Journal:  Am J Physiol Cell Physiol       Date:  2006-03-29       Impact factor: 4.249

6.  Cellular vimentin regulates construction of dengue virus replication complexes through interaction with NS4A protein.

Authors:  Catherine Su Hui Teo; Justin Jang Hann Chu
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

7.  Filamin A is required for vimentin-mediated cell adhesion and spreading.

Authors:  Hugh Kim; Fumihiko Nakamura; Wilson Lee; Yulia Shifrin; Pamela Arora; Christopher A McCulloch
Journal:  Am J Physiol Cell Physiol       Date:  2009-09-23       Impact factor: 4.249

8.  Cdc42GAP, reactive oxygen species, and the vimentin network.

Authors:  Qing-Fen Li; Amy M Spinelli; Dale D Tang
Journal:  Am J Physiol Cell Physiol       Date:  2009-06-03       Impact factor: 4.249

Review 9.  p130 Crk-associated substrate (CAS) in vascular smooth muscle.

Authors:  Dale D Tang
Journal:  J Cardiovasc Pharmacol Ther       Date:  2009-03-27       Impact factor: 2.457

Review 10.  Pak protein kinases and their role in cancer.

Authors:  Bettina Dummler; Kazufumi Ohshiro; Rakesh Kumar; Jeffrey Field
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.